Brainstorm Cell Therapeutics BCLI
OTC BCLI
$0.77 -0.02 (-2.53%)
As of: Oct 21, 2026 · 11:49 AM EDT

Brainstorm Cell Therapeutics (BCLI) Total Current Liabilities (2010 - 2026)

Updated

Brainstorm Cell Therapeutics (BCLI) recorded Total Current Liabilities of $12.39 million in Q2 2026, up 45.2% from $8.53 million a year earlier and up 5.3% from the prior quarter.

Analysis

Brainstorm Cell Therapeutics (BCLI) Total Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Brainstorm Cell Therapeutics reported Total Current Liabilities of $11.01 million, up 22.6% from FY2024.

  • Annual Total Current Liabilities has a five-year compound annual growth rate of -0.4% (FY2020 to FY2025).
  • Across earlier years, Total Current Liabilities came in at $8.98 million in FY2024 (+15.1%), $7.8 million in FY2023 (-11.4%), $8.8 million in FY2022 (+39.3%) and $6.32 million in FY2021 (-43.8%).
  • The Q2 2026 figure is the highest quarterly Total Current Liabilities since Q4 2019.
  • On a year-over-year basis, Total Current Liabilities has increased for eight consecutive quarters, with growth averaging 25.1% over the last eight quarters.
  • Peak year-over-year performance for Total Current Liabilities in the last five years was growth of 59.6% in Q1 2025, against a decline of 43.8% in Q4 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $11.76 million (Q1 2026), $11.01 million (Q4 2025) and $9.02 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 47.74 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 54.90 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 41.64 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 27.73 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 31.75 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 31.55 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 25.50 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 11.02 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 32.65 Bn
10 Brainstorm Cell Therapeutics 8.50 Mn 8.43 Mn - 12.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.39 Mn
Mar 31, 2026 11.76 Mn
Dec 31, 2025 11.01 Mn
Sep 30, 2025 9.02 Mn
Jun 30, 2025 8.53 Mn
Mar 31, 2025 10.90 Mn
Dec 31, 2024 8.98 Mn
Sep 30, 2024 7.08 Mn
Jun 30, 2024 7.69 Mn
Mar 31, 2024 6.83 Mn
Dec 31, 2023 7.80 Mn
Sep 30, 2023 6.32 Mn
Jun 30, 2023 7.69 Mn
Mar 31, 2023 10.42 Mn
Dec 31, 2022 8.80 Mn
Sep 30, 2022 8.95 Mn
Jun 30, 2022 7.85 Mn
Mar 31, 2022 7.37 Mn
Dec 31, 2021 6.32 Mn
Sep 30, 2021 5.85 Mn
API Access

Brainstorm Cell Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=BCLI&period=max&api_key=YOUR_API_KEY